Stanley SA, Grant SS, Kawate T, et al. Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. ACS Chem Biol. 2012;7(8):1377-84. doi:10.1021/cb300151m.

Reck F, Alm R, Brassil P, et al. Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II: broad-spectrum antibacterial agents with reduced hERG activity. J Med Chem. 2011;54(22):7834-47. doi:10.1021/jm2008826.

McMahon TC, Stanley S, Kazyanskaya E, Hung D, Wood JL. The first synthesis of an epidiselenodiketopiperazine. Org Lett. 2012;14(17):4534-6. doi:10.1021/ol3020094.

Stanley SA, Kawate T, Iwase N, et al. Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32. Proc Natl Acad Sci U S A. 2013;110(28):11565-70. doi:10.1073/pnas.1302114110.

Grant SS, Kawate T, Nag PP, et al. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model. ACS Chem Biol. 2013;8(10):2224-34. doi:10.1021/cb4004817.

Kawate T, Iwase N, Shimizu M, et al. Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32. Bioorg Med Chem Lett. 2013;23(22):6052-9. doi:10.1016/j.bmcl.2013.09.035.

Yoon E-J, Goussard S, Touchon M, et al. Origin in Acinetobacter guillouiae and dissemination of the aminoglycoside-modifying enzyme Aph(3’)-VI. MBio. 2014;5(5):e01972-14. doi:10.1128/mBio.01972-14.

Ford CB, Funt JM, Abbey D, et al. The evolution of drug resistance in clinical isolates of Candida albicans. Elife. 2015;4:e00662. doi:10.7554/eLife.00662.

Rock JM, Lang UF, Chase MR, et al. DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader. Nat Genet. 2015;47(6):677-81. doi:10.1038/ng.3269.

Isabella VM, Campbell AJ, Manchester J, et al. Toward the rational design of carbapenem uptake in Pseudomonas aeruginosa. Chem Biol. 2015;22(4):535-47. doi:10.1016/j.chembiol.2015.03.018.